AstraZeneca Partners with Oracle for AI Collaboration on Trials, Patient Care

MT Newswires · 2d ago
12:41 AM EDT, 10/20/2026 (MT Newswires) -- AstraZeneca (AZN.L, AZN.ST) signed a nonbinding term sheet with Oracle Health and Life Sciences to use artificial intelligence to optimize clinical trials and improve patient care. The biopharmaceutical company said Tuesday that the collaboration will explore projects across oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, and rare diseases. The first program will focus on hypertension care and clinical research in Abu Dhabi, United Arab Emirates, in partnership with healthcare company M42. It aims to help identify patients with uncontrolled hypertension and improve clinical trial recruitment.